ARP2-TZ 10 mg / 20 mg / 60 mg is a high-quality synthetic peptide formulated for advanced laboratory and preclinical research focused on metabolic regulation, incretin receptor biology, and glucose homeostasis pathways. Designed as a dual incretin receptor agonist, ARP2-TZ supports structured scientific investigation into dual receptor interactions, insulin signaling cascades, appetite modulation mechanisms, and systemic energy balance within controlled research environments.

Developed to assist researchers in examining complex endocrine responses, ARP2-TZ enables precise exploration of pancreatic beta-cell signaling, receptor activation dynamics, and downstream metabolic adaptations. Its refined molecular profile and high analytical purity make it suitable for in-vitro experimentation, receptor-binding studies, and preclinical metabolic research models where consistency and reproducibility are essential.

ARP2-TZ is offered in 10 mg, 20 mg, and 60 mg strengths to align with varying laboratory protocols, study durations, and structured research requirements.

Key Research Benefits:

• Dual incretin receptor activity: Supports investigation of complementary incretin receptor signaling pathways.
• Metabolic pathway analysis: Facilitates structured study of glucose regulation and insulin response mechanisms.
• Endocrine system research: Enables detailed examination of incretin-mediated hormonal interactions.
• High-purity lyophilized format: Designed to maintain stability, analytical accuracy, and reproducibility.
• Flexible research applications: Multiple strengths to accommodate diverse experimental protocols.

Applications:

• Incretin receptor pathway research
• Glucose metabolism and insulin signaling studies
• Energy balance and appetite regulation investigations
• Pancreatic and endocrine signaling analysis
• Cellular receptor activation research

For research use only. Not intended for human or veterinary use.